No Data
No Data
Express News | Today, a total of 84 stocks experienced block trades in the A-share market, with Qinghai Salt Lake Industry, Guizhou Chanhen Chemical Corporation, and Shanxi Xinghuacun Fen Wine Factory leading in trading volume.
Shanghai Sanyou Medical Co., Ltd (688085.SH): The Shanghai Stock Exchange's M&A and Restructuring Committee reviewed the asset restructuring matter on December 30.
On December 23, Gelonghui reported that Shanghai Sanyou Medical Co., Ltd (688085.SH) announced that the company plans to acquire a total of 37.1077% equity in Peking Shuimu Tianpeng Medical Technology Co., Ltd (hereinafter referred to as "Shuimu Tianpeng") held by Cao Qun and Xu Nong through the issuance of shares and payment in cash, and 98.9986% limited partner contribution interests in Shanghai Huanzhan Enterprise Management Partnership (Limited Partnership) (hereinafter referred to as "Shanghai Huanzhan") held by 11 transaction parties including Zhan Songtao. This will be done through its subsidiary, Tuoteng (Suzhou) Medical Technology Co., Ltd, which will acquire held by Zhangjiagang Tianpeng Investment Management Co., Ltd in cash.
Shanghai Sanyou Medical Co., Ltd acquires its controlling subsidiary at a 4 times premium, with the necessity of the Trade and performance commitments being key points of inquiry.
① Shanghai Sanyou Medical Co., Ltd intends to acquire the remaining shares of its subsidiary, Shuimu Tianpeng. An assessment indicates that Shuimu Tianpeng's value has increased by 0.693 billion yuan, with a value increase rate of 406.21%. ② Shanghai Sanyou Medical Co., Ltd stated that the acquisition is beneficial for enhancing the company's overall profitability. Prior to the acquisition, Shanghai Sanyou Medical Co., Ltd had consistently faced declining performance.
Shanghai Sanyou Medical Gets Registration Certificate for Ultrasonic Surgery Equipment
Deep Research on shanghai sanyou medical co., ltd(688085): the inflection point of performance has emerged, bullish on the future development of the company.
The company recently disclosed its third quarter report, with revenue for 2024Q1-Q3 decreasing by 7.30% year-on-year, and net income attributable to mother decreasing by 87.07% year-on-year. In Q3, revenue was 0.121 billion yuan, an increase of 57.30% year-on-year.
Shanghai Sanyou Medical Co., Ltd. (688085): The spine and ultrasonic knife business are gradually growing, actively expanding product lines.
Event: In the third quarter of 2024, shanghai sanyou medical co., ltd. achieved revenue of 0.121 billion yuan, a year-on-year increase of 57.30%; achieved a net income attributable to the parent of 6.89 million yuan, a year-on-year surge of 104.53%; In the first three quarters of 2024, shanghai sanyou medical co., ltd.
No Data